Cite
Relapsing generalized bullous fixed drug eruption: A severe and avoidable cutaneous drug reaction. Three case reports
MLA
Amandine Weill, et al. “Relapsing Generalized Bullous Fixed Drug Eruption: A Severe and Avoidable Cutaneous Drug Reaction. Three Case Reports.” Therapies, vol. 77, May 2022, pp. 378–81. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........9b1e8242d16ada5552cbb7830a5e2f5f&authtype=sso&custid=ns315887.
APA
Amandine Weill, Camille Hua, Nicolas Ortonne, Olivier Chosidow, Pierre Wolkenstein, Haudrey Assier, Clément Braesch, Laure Thomas, Lionel Nakad, Charlotte Bernigaud, Véronique Chambrin, Bénédicte Lebrun-Vignes, Saskia Ingen-Housz-Oro, & O. Gaudin. (2022). Relapsing generalized bullous fixed drug eruption: A severe and avoidable cutaneous drug reaction. Three case reports. Therapies, 77, 378–381.
Chicago
Amandine Weill, Camille Hua, Nicolas Ortonne, Olivier Chosidow, Pierre Wolkenstein, Haudrey Assier, Clément Braesch, et al. 2022. “Relapsing Generalized Bullous Fixed Drug Eruption: A Severe and Avoidable Cutaneous Drug Reaction. Three Case Reports.” Therapies 77 (May): 378–81. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........9b1e8242d16ada5552cbb7830a5e2f5f&authtype=sso&custid=ns315887.